Alyeska Investment Group
DVAX

Alyeska Investment Group’s Dynavax Technologies DVAX Stock Holding History

Alyeska Investment Group’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-104,200
Closed -$1.29M – 394
2018
Q3 		$1.29M Buy
+104,200
New +$1.41M 0.01% 333

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Alyeska Investment Group's DVAX Position: Q4 2018 in Review

Alyeska Investment Group sold out of Dynavax Technologies (DVAX) in Q4 2018, closing a stake of 104,200 shares — an estimated $1.29M sold.

Alyeska Investment Group first reported a position in DVAX in Q3 2018 and held it in 1 quarter. The position peaked at $1.29M in Q3 2018. 132 funds tracked by Wall St. Rank hold DVAX as of Q4 2018.

  • Alyeska Investment Group reported no remaining Dynavax Technologies position as of Q4 2018 after selling out during the quarter.
  • Alyeska Investment Group sold 104,200 Dynavax Technologies shares in Q4 2018, an estimated $1.29M.
  • Alyeska Investment Group first reported a position in Dynavax Technologies in Q3 2018 and held it in 1 quarter.
  • Alyeska Investment Group's Dynavax Technologies position peaked at $1.29M in Q3 2018.
  • 132 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2018.

Based on Alyeska Investment Group's 13F filing for Q4 2018, filed 14 Feb 2019.